Status:
COMPLETED
Treatment Outcomes of a Novel Glaucoma Tube Shunt Implant for Intraocular Pressure Control in Eyes With Refractory Glaucoma
Lead Sponsor:
National University Hospital, Singapore
Conditions:
Glaucoma
Glaucoma, Open-Angle
Eligibility:
All Genders
21-80 years
Brief Summary
The aim of this study is to determine the effectiveness of lowering intraocular pressure and safety profile of the Paul Glaucoma Implant (Advanced Ophthalmic Innovations, Singapore). This is a non-com...
Eligibility Criteria
Inclusion
- Age 21 - 80 years with glaucoma
- Poorly controlled intraocular pressure
Exclusion
- Unable to give informed consent
- Age below 21 or above 80 years
- Without any suitable quadrants for tube shunt implant
Key Trial Info
Start Date :
December 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2019
Estimated Enrollment :
82 Patients enrolled
Trial Details
Trial ID
NCT04297930
Start Date
December 1 2017
End Date
December 1 2019
Last Update
March 27 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National University Hospital
Singapore, Singapore